Biological

Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate clinical trials

Also written ActHIB™.

studies test it: 5
open now: 0
in phase 3: 3
first study started: 2001

How studies write it

Studies that test it under each name

Brand

ActHIB™: 3

Combined with it in one product

PPSV23, Act-HIB: 1
PPSV23=Pneumovax,: 1
ViscoGel® and 0.2μg Act-HIB®: 1
ViscoGel® and 2μg Act-HIB®: 1

Studies by the year they started

5 studies that test it; most in 2001 (1)

Studies that test Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate, by start year
Year	Studies
2001	1
2003	1
2005	1
2006	1
2012	1

By phase

A phase 1/2 study counts in both.

Phase 1: 1
Phase 2: 2
Phase 3: 3

What it is tested for

Each study’s main condition, where its own words name it.

Hepatitis A: 1
Meningitis: 1
Whooping Cough: 1

Who runs them

Industry 4 · Other 1

GlaxoSmithKline (2) · Uppsala University (1) · Sanofi Pasteur, a Sanofi Company (1) · Viscogel AB (1)

Often tested with

Tested in the same studies.

Diphtheria-Tetanus-acellular Pertussis Vaccines (2) · Hib-MenCY-TT vaccine (1) · 23-valent pneumococcal capsular polysaccharide vaccine (1) · Pneumococcal Vaccines (1) · Pentacel (1) · poly(ethylmethacrylate) (1)

Studies

Open first, then newest update. How each study uses Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate is read from its arms, and is right about nine times in ten.

Testing it · 5

Given in every arm · 2 — Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate is usual care beside what is tested

As the comparator · 14 — what is tested is compared with Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate